Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs bupivacaine + dexmedetomidine for brachial plexus block in radial fracture surgery
ChiCTR2500104926Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, Jiangsu Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jun 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Department of Anesthesiology, Jiangsu Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Postoperative VAS score. Started Jun 2025; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500104926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104926.